Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Metadata
Title
Ketoacidosis: an unusual presentation of MELAS
Authors
J. Strachan
A. McLellan
M. Kirkpatrick
R. Hume
D. Mechan
Publication date
01-06-2001
Publisher
Kluwer Academic Publishers
Published in
Journal of Inherited Metabolic Disease / Issue 3/2001
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1023/A:1010573122748

Other articles of this Issue 3/2001

Journal of Inherited Metabolic Disease 3/2001 Go to the issue

ReviewPaper

Plasma phenylalanine is asociated with decreased serum ubiquine-10 concentrations in phenylketonuria

ReviewPaper

Intermediates of unsaturated fatty acid oxidation are incorporated in triglycerides but not in phospholipids in tissues from patients with mitochondrial β-oxidation defects

ReviewPaper

Splenectomy in two siblings with G-CSF-dependent glycogen storage disease type Ib

ReviewPaper

Mevalonic aciduria and hyper-IgD syndrome: Two sides of the same coin?

ReviewPaper

A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping

ReviewPaper

Carnitine-responsive carnitine insufficiency in a case of mtDNA 8993T>C mutation associated Leigh syndrome

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits